High prevalence of olfactory impairment among leprosy patients: A cross-sectional study

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Dimensions
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
KONDO, Rogerio Nabor
ARAUJO, Milene Cripa Pizatto de
RAMOS, Paulo Muller
MIOT, Helio Amante
Citação
PLOS NEGLECTED TROPICAL DISEASES, v.17, n.4, article ID e0010888, 11p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BackgroundThe effect of leprosy on the sense of smell is not yet fully established. Studies that have relied only on patients' perceptions may have under- or over-estimated the change in smell perception. A validated and psychophysical method is necessary to avoid these errors in assessment. ObjectivesThis study aimed to validate the existence of olfactory involvement in leprosy patients. MethodsA cross-sectional, controlled study was conducted, in which individuals with leprosy (exposed individuals) and individuals without leprosy (control patients) were recruited. For each exposed individual, we selected two control patients. A total of 108 patients (72 control patients and 36 exposed individuals) with no history of infection with the new coronavirus (COVID-19) took the University of Pennsylvania Smell Identification Test (UPSIT). ResultsMost exposed individuals had olfactory dysfunction [n = 33, 91.7% (CI 95%: 77.5%-98.3%)] when compared with the control patients [n = 28, 38.9% (CI 95%: 27.6%-51.1%)], but only two (5.6%) had olfactory complaints. The olfactory function was significantly worse among exposed individuals [UPSIT leprosy = 25.2 (CI 95%: 23.1-27.3) when compared with the UPSIT control patients = 34.1 (CI 95%: 33.0-35.3); p<0.001]. The risk of olfactory loss was higher among the exposed individuals [OR: 19.5 (CI 95%: 5.18-105.70; p < 0.001)]. ConclusionsOlfactory dysfunction was highly prevalent among exposed individuals, although they had little or no self-knowledge of the disorder. The results show that it is important to assess the sense of smell in exposed individuals. Author summaryLeprosy is one of the oldest neurocutaneous diseases in the world. However, it has been neglected by the general population, doctors, and scientists. Transmitted by Mycobacterium leprae and Mycobacterium lepromatosis, leprosy is met with stigma and prejudice. Some patients with leprosy (exposed individuals) keep their diagnosis a secret, fearing a negative impact on their social lives. The disease is characterized by white or red skin lesions associated with local numbness. Few studies have evaluated smell among exposed individuals, but they have not used the University of Pennsylvania Smell Identification Test (UPSIT), which is a validated psychophysical method. The present study found a high prevalence of olfactory impairment (91.7%) among exposed individuals, accompanied by low self-knowledge of the disorder (5.6%). It is thus important to assess the sense of smell in infected individuals, as this sensorineural assessment has not been performed as a routine for patients.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/59102
Referências
  1. Araújo Marcelo Grossi, 2003, Rev. Soc. Bras. Med. Trop., V36, P373, DOI 10.1590/S0037-86822003000300010
  2. BARTON RPE, 1976, ANN OTO RHINOL LARYN, V85, P74, DOI 10.1177/000348947608500113
  3. Boscolo-Rizzo P, 2021, CHEM SENSES, V46, DOI 10.1093/chemse/bjab006
  4. Camacho Ivan D, 2011, Ear Nose Throat J, V90, pE1
  5. Bottene IMC, 2012, AN BRAS DERMATOL, V87, P408, DOI 10.1590/S0365-05962012000300009
  6. Doty RL, 2018, OTOLARYNG CLIN N AM, V51, P815, DOI 10.1016/j.otc.2018.03.014
  7. Doty RL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00020
  8. Fornazieri MA, 2019, PHYSIOL BEHAV, V198, P84, DOI 10.1016/j.physbeh.2018.10.011
  9. Fornazieri MA, 2013, CLINICS, V68, P65, DOI 10.6061/clinics/2013(01)OA10
  10. Foss N. T., 1999, Anais Brasileiros de Dermatologia, V74, P113
  11. Han XY, 2008, AM J CLIN PATHOL, V130, P856, DOI 10.1309/AJCPP72FJZZRRVMM
  12. Horikiri K, 2017, ACTA OTO-LARYNGOL, V137, P1083, DOI 10.1080/00016489.2017.1325005
  13. KOYUNCU M, 1995, INT J LEPROSY, V63, P23
  14. Lescaille Torres Torre Juan Gualberto, 2015, Rev Cubana Med Gen Integr, V31, P52
  15. Menon C, 2013, CLIN NEUROPSYCHOL, V27, P946, DOI 10.1080/13854046.2013.796406
  16. Mishra A, 2006, LARYNGOSCOPE, V116, P413, DOI 10.1097/01.MLG.0000195001.03483.F2
  17. Naaz F, 2017, INT J MYCOBACT, V6, P222, DOI 10.4103/ijmy.ijmy_70_17
  18. Navon L, 1998, SOC HIST MED, V11, P89, DOI 10.1093/shm/11.1.89
  19. Pavezzi PD, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008585
  20. Prevedello Flávia Costa, 2007, An. Bras. Dermatol., V82, P451, DOI 10.1590/S0365-05962007000500009
  21. Soni N K, 1992, Indian J Lepr, V64, P325
  22. Veyseller B, 2012, INDIAN J OTOLARYNGOL, V64, P261, DOI 10.1007/s12070-011-0284-9
  23. Yowan P, 2002, Indian J Lepr, V74, P129
  24. ,, 2016, Weekly Epidemiological Record, V91, P405

Coleções
Artigos e Materiais de Revistas Científicas - FM/Outros
Artigos e Materiais de Revistas Científicas - COVID-19